POLATUZUMAB VEDOTIN WITH BENDAMUSTINE AND RITUXIMAB FOR RELAPSED/REFRACTORY HIGH‐GRADE B‐CELL LYMPHOMA: THE UK EXPERIENCE. (17th June 2021) - Northend, M.; Wilson, W.; Osborne, W.; Fox, C. P.; Davies, A. J; El‐Sharkawi, D.; Phillips, E. H.; Sim, H. W.; Sadullah, S.; Shah, N.; Peng, Y. Y.; Qureshi, I.; et al.